drugset

drugset / Trial / NCT00043446

Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.

NCT00043446 ↗

Phase 2 Unknown 35 enrolled Tularik

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether T900607-sodium is effective and safe in treating ovarian cancer.

Timeline

Start: 2002-07
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	T900607	Small molecule	—	Intravenous

Indications